Kenya Antifungal Drug Market Insights and In-Depth Analysis 2023-2028 with Types, Products and Key Players

The Kenya Antifungal Drug Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the global Kenya Antifungal Drug market. This report explores all the key factors affecting the growth of the global Kenya Antifungal Drug market, including demand-supply scenario, pricing structure, profit margins, production, and value chain analysis.

Get PDF Sample Report Now! @ https://www.prudentmarkets.com/sample-request/141654/

Report Overview

The Antifungal drug market size in Kenya stood at USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period

Antifungal drugs are used to treat fungal infections caused by a wide range of fungi. Common fungal infections prevalent among Kenyan population are Tinea capitis, Oral candidiasis, Oesophageal candidiasis, Vaginal candidiasis, Chronic Pulmonary Aspergillosis, Cryptococcal meningitis, Pneumocystis pneumonia and Fungal keratitis. The high burden of fungal infections may be attributed to opportunistic infections in HIV and TB patients. It is estimated that, at any one time, about 7% of the Kenyan population suffers from a significant fungal infection, with recurrent vaginitis and tinea capitis accounting for 82% of the infections.The antifungal drugs are available in different formulations (oral tablet, oral capsule, cream, shampoo, sterile IV solution, lotion, vaginal cream, and ointments).

Market Drivers

The market is majorly driven due to the high prevalence of fungal infections in Kenya.

Approximately 594,660 Kenyan women get more than 4 episodes Candida vulvovaginitis annually and Tinea capitis infects 9.6% of children in Kenya.

Oral thrush, Oesophageal candidiasis, Cryptococcal meningitis and Pneumocystis pneumonia are common opportunistic infection among HIV infected patients.Chronic Pulmonary Aspergillosis is prevalent following Tuberculosis infection.

Kenya has approximately 40% of its population in the age group 0-15 years. This age group is highly susceptible to fungal infections like Tinea capitis.

Increase in the number of hospital-acquired infections is expected to augment growth of antifungal drug market.

In most parts of the coast, relative humidity is high year-round which presents ideal temperature of the fungi to thrive and grow causing high incidence of fungal infections in coastal regions.

However, increased resistance has been observed among the Candida and Aspergillus species towards antifungal drugs is restraining the growth of antifungal market.

 

To Know More About COVID-19 Impact On Kenya Antifungal Drug Market @ https://www.prudentmarkets.com/sample-request/141654/

Market Segmentation

By Drug Class:

The Anti-fungal Drugs market is segmented by Drug Class into Echinocandins, Azoles, Polyenes, Allylamines, and Other Drug Classes

Azoles drug class dominates the market with leading therapeutic agents such as Noxafil, Diflucan, and Cresemba. The dominance of the market can be attributed to broad-spectrum activity delivered by Azoles. These agents support fungistatic activities by inhibiting fungal enzymes. Azoles are used in the treatment of candidemia, blastomycosis, systemic candidiasis, and ocular fungal infections.

By Distribution Channel:

On the basis of distribution channel, the market for Antifungal drugs can be segmented into hospital pharmacies, retail pharmacies, online pharmacies, and others.

Retail pharmacy segment holds the dominant share and is projected to high growth rates throughout the forecast period.

By Route of Administration:

On the basis of route of administration, the market can be segmented into Oral, Topical and Parenteral.

Topical segment holds the dominant share in terms of revenue generated.

Major Players

Some of the players in the market are Glenmark Pharmaceuticals, Abbott, Novartis AG, Merck & Co., Inc., Sanofi-Aventis, Bayer AG, and GlaxoSmithKline Plc.

Glenmark's top selling antifungal topical preparations include Candid Antifungal Powder and Cream to treat fungal skin Infections like yeast infections, ringworm and vaginal thrush.

Domestic pharmaceutical companies operating in Kenya leading in the antifungal drug market are DAWA Limited, Cosmos Limited, Didy Pharmaceuticals, Beta healthcare and Universal Pharmaceutical Limited.

Prudent Markets provides attractive discounts that fit your needs. Customization of the reports as per your requirement is also offered. Get in touch with our sales team, who will guarantee you a report that suits your needs.

Speak To Our Analyst For A Discussion On The Above Findings, And Ask For A Discount On The Report @ https://www.prudentmarkets.com/discount-request/141654/

The report covers the competitive analysis of the market. As the demand is driven by a buyer's paying capacity and the rate of item development, the report shows the important regions that will direct growth. This section exclusively shares insight into the budget reports of big-league members of the market helping key players and new entrants understand the potential of investments in the Global Kenya Antifungal Drug Market. It can be better employed by both traditional and new players in the industry for complete know-how of the market.

Strategic Points Covered in Table of Content of Global Kenya Antifungal Drug Market:

Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the Kenya Antifungal Drug market
Chapter 2: Exclusive Summary - the basic information of the Kenya Antifungal Drug Market.
Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges & Opportunities of the Kenya Antifungal Drug
Chapter 4: Presenting the Kenya Antifungal Drug Market Factor Analysis, Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.
Chapter 5: Displaying the by Type, End User and Region/Country
Chapter 6: Evaluating the leading manufacturers of the Kenya Antifungal Drug market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile
Chapter 7: To evaluate the market by segments, by countries and by Manufacturers/Company with revenue share and sales by key countries in these various regions
Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source

Any Questions? Feel Free To Enquire Here. We Will put you on the Right Path @ https://www.prudentmarkets.com/enquiry-request/141654/

Free Customization on the basis of client requirements on Immediate purchase:
1- Free country-level breakdown of any 5 countries of your interest.
2- Competitive breakdown of segment revenue by market players.

Customization of the Report:
This report can be customized to meet the client's requirements. Please connect with our sales team (sales@prudentmarkets.com), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +91 83560 50278 || USA/Canada(Toll Free): 1800-601-6071 to share your research requirements.

Get ready to Recognize the pros and cons of the regulatory framework, local reforms, and its effect on the Industry. Understand how the Leaders in Intelligent Network are keeping themselves one stage forward with our most up-to-date survey analysis.

In conclusion, the Kenya Antifungal Drug Market report is a genuine source for accessing the research data which is projected to exponentially grow your business. The report provides information such as economic scenarios, benefits, limits, trends, market growth rates, and figures. SWOT analysis and PESTLE analysis is also incorporated in the report.

Contact Us:
Allan Carter
Andheri, Maharashtra, 400102
USA/Canada(Toll Free): 1800-601-6071
Direct Line: +91 83560 50278
Mail: sales@prudentmarkets.com
Web: www.prudentmarkets.com

About Us:
We are leaders in market analytics, business research, and consulting services for Fortune 500 companies, start-ups, financial & government institutions. Since we understand the criticality of data and insights, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. To be at our client's disposal whenever they need help on market research and consulting services. We also aim to be their business partners when it comes to making critical business decisions around new market entry, M&A, competitive Intelligence and strategy.

This release was published on openPR.